<DOC>
	<DOCNO>NCT02018939</DOCNO>
	<brief_summary>The study conduct investigate pharmacokinetics Doripenem CVVHDF ( Continuous venovenous hemodiafiltration ) , MARS ( Molecular Adsorbent Recirculating System ) intermittent hemodialysis .</brief_summary>
	<brief_title>Multiple-dose Pharmacokinetics Doripenem During Continuous Venovenous Hemodiafiltration Molecular Adsorbent Recirculating System ICU Patients During Hemodialysis Longterm Hemodialysis Patients .</brief_title>
	<detailed_description />
	<criteria>Age &gt; 18 year Suspected proven bacterial infection require parenteral antibiotic therapy . Organ replacement therapy ( MARS , CVVHDF HD ) Known hypersensitivity doripenem carbapenems , severe hypersensitivity ( anaphylactic reaction ) betalactam antibacterial agent . An expected survival less two day . Known pregnancy Coadministration valproic acid probenecid , discontinue duration study Doripenem monotherapy resistent specie fungal infection . Other reason oppose study participation discretion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>pharmacokinetics , doripenem , renal replacement therapy , MARS , organ replacement therapy</keyword>
</DOC>